This infographic highlights clinical trial results showing mixed efficacy and increased adverse events in patients with IgAN treated with corticosteroids. Read More
The goal of this on-demand webinar is to provide a detailed overview of the Four-Hit hypothesis as well as explain the role of APRIL in disease pathogenesis. Read More
The Kidney Care Choices (KCC) Model is designed to bring groups of nephrologists and other kidney care providers together to take responsibility for patients who have late-stage chronic kidney disease,… Read More
This webinar discussion featuring Dr. Ashar Luqman will discuss the prevalence of various common and rare kidney diseases and comorbidities among the Native American population. Read More
This podcast provides an in-depth review of the Oxford MEST-C score, focusing on its practical application in diagnosing and prognosticating IgA Nephropathy. Read More
Through the lens of renal pathology, this webinar will provide insights into the histopathological features that are crucial for accurate diagnosis and risk stratification in IgA Nephropathy, highlighting the significance… Read More
NephU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) and Otsuka America Pharmaceutical, Inc. (OAPI) - committed supporters of the Kidney Health Community. The information provided through NephU is intended for the educational benefit of health care professionals and others who support care for those with kidney disease and other related conditions. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing NephU’s educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by NephU. Some of the contributors may be paid consultants of OPDC and/or OAPI.